249 related articles for article (PubMed ID: 26292259)
1. Loss of NDRG2 promotes epithelial-mesenchymal transition of gallbladder carcinoma cells through MMP-19-mediated Slug expression.
Lee DG; Lee SH; Kim JS; Park J; Cho YL; Kim KS; Jo DY; Song IC; Kim N; Yun HJ; Park YJ; Lee SJ; Lee HG; Bae KH; Lee SC; Shim S; Kim YM; Kwon YG; Kim JM; Lee HJ; Min JK
J Hepatol; 2015 Dec; 63(6):1429-39. PubMed ID: 26292259
[TBL] [Abstract][Full Text] [Related]
2. Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL/MAPK pathway.
Li M; Lu J; Zhang F; Li H; Zhang B; Wu X; Tan Z; Zhang L; Gao G; Mu J; Shu Y; Bao R; Ding Q; Wu W; Dong P; Gu J; Liu Y
Cancer Lett; 2014 Dec; 355(2):201-9. PubMed ID: 25218593
[TBL] [Abstract][Full Text] [Related]
3. MiR-20a triggers metastasis of gallbladder carcinoma.
Chang Y; Liu C; Yang J; Liu G; Feng F; Tang J; Hu L; Li L; Jiang F; Chen C; Wang R; Yang Y; Jiang X; Wu M; Chen L; Wang H
J Hepatol; 2013 Sep; 59(3):518-27. PubMed ID: 23665284
[TBL] [Abstract][Full Text] [Related]
4. Hedgehog signaling pathway is a potential therapeutic target for gallbladder cancer.
Matsushita S; Onishi H; Nakano K; Nagamatsu I; Imaizumi A; Hattori M; Oda Y; Tanaka M; Katano M
Cancer Sci; 2014 Mar; 105(3):272-80. PubMed ID: 24438533
[TBL] [Abstract][Full Text] [Related]
5. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
6. NDRG2 down-regulation and CD24 up-regulation promote tumor aggravation and poor survival in patients with gallbladder carcinoma.
Song SP; Zhang SB; Liu R; Yao L; Hao YQ; Liao MM; Zhang YD; Li ZH
Med Oncol; 2012 Sep; 29(3):1879-85. PubMed ID: 22135002
[TBL] [Abstract][Full Text] [Related]
7. miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.
Bao RF; Shu YJ; Hu YP; Wang XA; Zhang F; Liang HB; Ye YY; Li HF; Xiang SS; Weng H; Cao Y; Wu XS; Li ML; Wu WG; Zhang YJ; Jiang L; Dong Q; Liu YB
Oncotarget; 2016 Apr; 7(16):22339-54. PubMed ID: 26968949
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-related receptor-α promotes gallbladder cancer development by enhancing the transcription of Nectin-4.
Wang L; Yang M; Guo X; Yang Z; Liu S; Ji Y; Jin H
Cancer Sci; 2020 May; 111(5):1514-1527. PubMed ID: 32030850
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo.
Qin Y; Zhou Y; Ge A; Chang L; Shi H; Fu Y; Luo Q
Biomed Pharmacother; 2019 Oct; 118():109266. PubMed ID: 31401397
[TBL] [Abstract][Full Text] [Related]
10. ΔNp63α Promotes Breast Cancer Cell Motility through the Selective Activation of Components of the Epithelial-to-Mesenchymal Transition Program.
Dang TT; Esparza MA; Maine EA; Westcott JM; Pearson GW
Cancer Res; 2015 Sep; 75(18):3925-35. PubMed ID: 26292362
[TBL] [Abstract][Full Text] [Related]
11. The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer.
Zhang M; Gong W; Zuo B; Chu B; Tang Z; Zhang Y; Yang Y; Zhou D; Weng M; Qin Y; Ma M; Jiang A; Ma F; Quan Z
Oncotarget; 2016 Nov; 7(48):78640-78652. PubMed ID: 27769047
[TBL] [Abstract][Full Text] [Related]
12. Lysine-specific demethylase 1 promotes tumorigenesis and predicts prognosis in gallbladder cancer.
Lian SX; Shao YB; Liu HB; He JY; Lu WQ; Zhang Y; Jiang Y; Zhu J
Oncotarget; 2015 Oct; 6(32):33065-76. PubMed ID: 26460616
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer.
Ma F; Wang SH; Cai Q; Zhang MD; Yang Y; Ding J
Biomed Pharmacother; 2016 Dec; 84():1249-1255. PubMed ID: 27810781
[TBL] [Abstract][Full Text] [Related]
14. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of ASPP2 promotes gallbladder cancer metastasis and macrophage recruitment via aPKC-ι/GLI1 pathway.
Tian L; Deng Z; Xu L; Yang T; Yao W; Ji L; Lu Y; Zhang J; Liu Y; Wang J
Cell Death Dis; 2018 Nov; 9(11):1115. PubMed ID: 30389910
[TBL] [Abstract][Full Text] [Related]
16. METTL3 promotes ovarian carcinoma growth and invasion through the regulation of AXL translation and epithelial to mesenchymal transition.
Hua W; Zhao Y; Jin X; Yu D; He J; Xie D; Duan P
Gynecol Oncol; 2018 Nov; 151(2):356-365. PubMed ID: 30249526
[TBL] [Abstract][Full Text] [Related]
17. Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway.
Liu ZY; Cao J; Zhang JT; Xu GL; Li XP; Wang FT; Ansari KH; Mohamed H; Fan YZ
Oncotarget; 2017 Jul; 8(30):49897-49914. PubMed ID: 28611292
[TBL] [Abstract][Full Text] [Related]
18. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y
J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of desmoglein 2 promotes EMT progression in gallbladder cancer.
Wang L; Lv Y; Li J; Nan Y; Piao L; Liang Z
Histol Histopathol; 2023 Apr; 38(4):467-474. PubMed ID: 36259602
[TBL] [Abstract][Full Text] [Related]
20. Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancer.
Kawamoto M; Onishi H; Ozono K; Yamasaki A; Imaizumi A; Kamakura S; Nakano K; Oda Y; Sumimoto H; Nakamura M
Oncotarget; 2017 May; 8(22):36211-36224. PubMed ID: 28423707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
